[CAS NO. 2413192-59-1] HBV-IN-29
PRODUCTS SPECIFICATIONS [2413192-59-1]
DESCRIPTION [2413192-59-1]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 414.84 |
| Molecular Formula | C22H19ClO6 |
| SMILES | O=C(O)COC1CC(COC2=CC=C(C3=CC(C4=CC=CC(Cl)=C4O3)=O)C=C2)C1 |
Summary
In Vitro
HBV-IN-29 (ex8; 24 h) inhibits HBeAg levels and cell viability with an IC
50
value of 1.34 μM in HepDES19 cells. HepDES19 is the cell line that produces cccDNA
[1]
.
HBV-IN-29 (5 days) decreases cccDNA levels in HepDES19 cells in a dose-dependent manner
[1]
.
HBV-IN-29 (9 days; primary human hepatocyte (PHH)) has anti-HBV effect and inhibits HBeAg with an IC
50
value of 0.12 μM
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.